Antidepressants Are Associated With a Reduction in the Risk of Death in COVID-19 Disease Patients
- PMID: 36856572
- DOI: 10.1097/MJT.0000000000001618
Antidepressants Are Associated With a Reduction in the Risk of Death in COVID-19 Disease Patients
Conflict of interest statement
The authors have no conflicts of interest to declare.
References
-
- Symptoms of Novel Coronavirus (2019-nCoV). Available at: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html . US Centers for Disease Control and Prevention. Accessed on 9 February 2022.
-
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet. 2020;395:497–506.
-
- Liu B, Li M, Zhou Z, et al. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J Autoimmun. 2020;111:102452.
-
- Kroeze Y, Zhou H, Homberg JR. The genetics of selective serotonin reuptake inhibitors. Pharmacol Ther. 2012;136:375–400.
-
- Gałecki P, Mossakowska-Wojcik J, Talarowska M. The anti-inflammatory mechanism of antidepressants -SSRIs. SNRIs. Prog Neuropsychopharmacol Biol Psychiatry. 2018;80:291–294.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical